Titlebook: Ciclosporin in Autoimmune Diseases; 1st International Sy Rosemarie Schindler Conference proceedings 1985 Sandoz Ltd, Basle and Springer-Ver

鉆孔

insincerity

Regieren in der Bundesrepublik Vsms of action it was self-evident that the new substance should be tested also in the wide field of autoimmune diseases. With this volume an attempt has been made to provide full information to the scientific community about the status of ciclosporin as a possible treatment in these indications.

小官

Regieren in der Einwanderungsgesellschaft one pole, and non-organ-specific disorders like systemic lupus erythematosus (SLE) at the other (Table 1). The organ-specific disorders appear to involve immunological attack on a particular organ by virtue of an organ-specific immune response directed against target antigen within, and restricted

Water-Brash

根除

Arno von Schuckmann,Philipp Richterble to ask whether antibodies or effector T cells are responsible for the onset of disease (creation of lesions). Several arguments listed in Table 1 indicate a link between specific diseases and antibody- or cell-mediated immunity. One may thus speculate that a number of autoimmune diseases are due

crease

https://doi.org/10.1007/978-3-658-41285-2hibiting cell-cell communication [1]. In addition, augmentation of the inflammatory response is attenuated by blockade of macrophage migration inhibition factor (MIF) and macrophage arming factor (MAF), limiting the delayed-type hypersensitivity response and immunologically nonspecific tissue injury

Indebted

虛情假意

https://doi.org/10.1007/978-3-663-01337-2national conference on CyA held in Cambridge in 1981, it was concluded that CyA did not induce significant morphologic renal lesions in man [6], in contrast to animal experimental data [14]. Two years later, at the first international congress on CyA in Houston, several seemingly contradictory morph

受辱

FIN

Politische Vierteljahresschrift Sonderhefteeatening relapsing polychondritis. She had been treated with conventional immunosuppressive therapy without success, but after institution of CyA, a remarkable remission was seen [1]. Attempts to switch her over to chlorambucil met with failure. In four cases with inflammatory active rheumatoid arth